Valuation GlaxoSmithKline plc LIQUIDNET SYSTEMS

Stocks

Delayed LIQUIDNET SYSTEMS Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-

02:00pm	GSK : JP Morgan gives a Sell rating	ZD
08-03	GSK India first-quarter profit rises on steady vaccine demand	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	76,514	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	4.53%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	95,043	91,589	88,343
Change	-	-24.65%	-1.89%	-8.24%	28.83%	8.43%	-3.63%	-3.54%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	13.2x	11.5x	10.7x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.56x	3.87x	3.36x
PEG	-	0x	-0.2x	-0.4x	0x	4.98x	0.8x	1.43x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.25x	2.15x	2.08x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.8x	2.57x	2.4x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.16x	7.41x	6.89x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.23x	8.22x	7.6x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	15.7x	15.5x	13.4x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.38%	6.45%	7.46%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7315	0.7632
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.64%	3.83%	4%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.448	1.653	1.777
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	48%	44.2%	42.9%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,973	35,624	36,778
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,654	12,363	12,828
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,293	11,143	11,626
Net income ¹	4,385	14,956	4,928	2,575	5,716	5,869	6,674	7,204
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	18,530	15,075	11,829
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.10	19.10	19.10
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,007,011	-	-
Announcement Date	9/2/22	1/2/23	31/1/24	5/2/25	4/2/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.19x	11.9x	25x	0.6%	1T
JOHNSON & JOHNSON	27.59x	6.24x	17.41x	2.11%	613B
ABBVIE INC.	33.42x	7.23x	14.91x	2.82%	433B
ROCHE HOLDING AG	19.84x	4.71x	11.66x	2.81%	350B
NOVARTIS AG	21.78x	5.64x	14.07x	2.85%	292B
ASTRAZENECA PLC	19.76x	4.1x	11.62x	2.15%	239B
NOVO NORDISK A/S	13.29x	4.98x	10.27x	3.76%	206B
AMGEN INC.	24.88x	6.52x	11.5x	2.66%	204B
GILEAD SCIENCES, INC.	-47.26x	5.67x	31.29x	2.51%	163B
Average	16.39x	6.33x	16.42x	2.48%	388.94B
Weighted average by Cap.	23.92x	7.55x	17.90x	2.05%